Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine and Bortezomib in Relapsed/Refractory Indolent NHL or B-CLL
NCT00426855Phase 2Completed
- Start
- Jan 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of bendamustine in non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL). Started Jan 2007; status: completed.
02
Drugs
bendamustine
03
Conditions
non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00426855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426855.